TAIAN CITY, Shandong, China, Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company will present at the upcoming SIG Second Annual Beijing Management Summit held September 10 - 12, 2008 at the Grand Hyatt Beijing Hotel in Beijing.
The SIG Second Annual Beijing Management Summit is a two-and-a-half-day
conference that brings together executives from public and private
companies based in China and other emerging Asian economies. The event will
showcase leading companies in the Chinese consumer, health care, Internet,
and technology sectors, as well as companies in the global business
services sector. Details of China Biologic's presentation follow.
Date: Thursday, September 11, 2008
Time: 3:20 p.m. Beijing time
Venue: The Grand Hyatt Beijing
1 East Chang An Avenue
During the conference, the Company will be available to meet with analysts and portfolio managers. Participation in the SIG Second Annual Beijing Management Summit is by invitation only. Further information can be found at http://www.sig.com .
About China Biologic Products, Inc.
Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Safe Harbor Statement
This release m
|SOURCE China Biologic Products, Inc.|
Copyright©2008 PR Newswire.
All rights reserved